Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jimenez

Showing results (31-40 of 392) with videos related to

Pageof 40
Sort By:
JAAPA : Official Journal of the American Academy of Physician Assistants|March 4, 2009
What is your diagnosis? Osteitis pubisChris A Webb, Matthew L Jimenez
MCN. the American Journal of Maternal Child Nursing|September 1, 1980
Supplemental information for the family with a multiple pregnancyS L Jimenez, R G Jungman
Cryobiology|February 21, 2006
Thermal expansion of blood vessels in low cryogenic temperatures Part I: A new experimental deviceJorge L Jimenez Rios, Yoed Rabin
Journal of Microbiological Methods|August 26, 2000
Use of PCR analysis for detecting low levels of bacteria and mold contamination in pharmaceutical samplesL Jimenez, S Smalls, R Ignar
Journal of the American Chemical Society|December 20, 2011
Deuterium kinetic isotope effects in the 1,4-dimethylenecyclohexane boat Cope rearrangementJ J Gajewski, J L Jimenez
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1973
Role of cyclic 3':5'-adenosine monophosphate in the early transport changes induced by serum and insulin in quiescent fibroblastsE Rozengurt, L Jimenez de Asua
Circulation|August 5, 1997
Long-term consequences of Kawasaki diseaseO H Teixeira, C L Jimenez
Journal of Cellular Physiology|April 1, 1983
Microtubule-disrupting agents can independently affect the prereplicative period and the entry into S phase stimulated by prostaglandin F2 alpha and fibroblastic growth factorA M Otto, L Jimenez de Asua
Biometrical Journal. Biometrische Zeitschrift|May 30, 2018
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agentsJose L Jimenez, Mourad Tighiouart, Mauro Gasparini
Indoor Air|May 27, 2022
Systematic way to understand and classify the shared-room airborne transmission risk of indoor spacesJose L Jimenez, Zhe Peng, Demetrios Pagonis
Pageof 40

Showing results (31-40 of 392) with videos related to

Sort By:
Pageof 40
JAAPA : Official Journal of the American Academy of Physician Assistants|March 4, 2009
What is your diagnosis? Osteitis pubisChris A Webb, Matthew L Jimenez
MCN. the American Journal of Maternal Child Nursing|September 1, 1980
Supplemental information for the family with a multiple pregnancyS L Jimenez, R G Jungman
Cryobiology|February 21, 2006
Thermal expansion of blood vessels in low cryogenic temperatures Part I: A new experimental deviceJorge L Jimenez Rios, Yoed Rabin
Journal of Microbiological Methods|August 26, 2000
Use of PCR analysis for detecting low levels of bacteria and mold contamination in pharmaceutical samplesL Jimenez, S Smalls, R Ignar
Journal of the American Chemical Society|December 20, 2011
Deuterium kinetic isotope effects in the 1,4-dimethylenecyclohexane boat Cope rearrangementJ J Gajewski, J L Jimenez
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1973
Role of cyclic 3':5'-adenosine monophosphate in the early transport changes induced by serum and insulin in quiescent fibroblastsE Rozengurt, L Jimenez de Asua
Circulation|August 5, 1997
Long-term consequences of Kawasaki diseaseO H Teixeira, C L Jimenez
Journal of Cellular Physiology|April 1, 1983
Microtubule-disrupting agents can independently affect the prereplicative period and the entry into S phase stimulated by prostaglandin F2 alpha and fibroblastic growth factorA M Otto, L Jimenez de Asua
Biometrical Journal. Biometrische Zeitschrift|May 30, 2018
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agentsJose L Jimenez, Mourad Tighiouart, Mauro Gasparini
Indoor Air|May 27, 2022
Systematic way to understand and classify the shared-room airborne transmission risk of indoor spacesJose L Jimenez, Zhe Peng, Demetrios Pagonis
Pageof 40